Literature DB >> 21809319

Measurement of proliferative responses of cultured lymphocytes.

Linda Mesler Muul1, Guido Heine, Christopher Silvin, Stephen P James, Fabio Candotti, Andreas Radbruch, Margitta Worm.   

Abstract

Measurement of proliferative responses of human lymphocytes is a fundamental technique for the assessment of their biological responses to various stimuli. Most simply, this involves measurement of the number of cells present in a culture before and after the addition of a stimulating agent. This unit contains several different prototype protocols to induce proliferation in lymphocytes following exposure to mitogens, antigens, allogeneic or autologous cells, or soluble factors. Each of these protocols can be used in conjunction with an accompanying protocol, which contains methods to determine cell proliferation by incorporation of [(3)H]thymidine into DNA by nonradioactive methods, e.g., reduction of tetrazolium salts (MTT or WST-1). These protocols provide an estimate of cell proliferation indirectly by measuring DNA synthesis, and cell metabolic activity in an entire cell population, but no data on individual cells is obtained. A protocol for CFSE labeling allows direct detection of single proliferating cells and facilitates the quantification of cell divisions by flow cytometry according to the respective CFSE-dilution, and following costaining with fluorescent labeled antibodies, the characterization of subpopulations in the cell culture.
© 2011 by John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21809319     DOI: 10.1002/0471142735.im0710s94

Source DB:  PubMed          Journal:  Curr Protoc Immunol        ISSN: 1934-3671


  8 in total

1.  Assessment of the Immunomodulatory Properties of Human Mesenchymal Stem Cells (MSCs).

Authors:  Pei-Ju Hsu; Ko-Jiunn Liu; Ying-Yin Chao; Huey-Kang Sytwu; B Linju Yen
Journal:  J Vis Exp       Date:  2015-12-24       Impact factor: 1.355

2.  Efficient Culture of Human Naive and Memory B Cells for Use as APCs.

Authors:  Kuei-Ying Su; Akiko Watanabe; Chen-Hao Yeh; Garnett Kelsoe; Masayuki Kuraoka
Journal:  J Immunol       Date:  2016-10-10       Impact factor: 5.422

3.  Induced pluripotent stem cells have similar immunogenic and more potent immunomodulatory properties compared with bone marrow-derived stromal cells in vitro.

Authors:  Lauren V Schnabel; Christian M Abratte; John C Schimenti; M Julia Bevilaqua Felippe; Jennifer M Cassano; Teresa L Southard; Jessica A Cross; Lisa A Fortier
Journal:  Regen Med       Date:  2014-04-28       Impact factor: 3.806

4.  Chromosome preparation from cultured cells.

Authors:  Bradley Howe; Ayesha Umrigar; Fern Tsien
Journal:  J Vis Exp       Date:  2014-01-28       Impact factor: 1.355

5.  Renal transplant recipient with advanced HIV infection: graft and peripheral cell population analysis.

Authors:  Ian C Bostock; Janette Furuzawa-Carballeda; Diana Gómez-Martín; Guadalupe Lima; Alexandra Martin-Onraët; Juan Sierra; Norma O Uribe-Uribe; Mario Vilatobá; Alan G Contreras; Bernardo Gabilondo; Luis E Morales-Buenrostro; Josefina Alberú
Journal:  Clin Case Rep       Date:  2013-11-18

6.  In vivo and in vitro biocompatibility study of novel microemulsion hybridized with bovine serum albumin as nanocarrier for drug delivery.

Authors:  Mahmoud Gharbavi; Hamidreza Kheiri Manjili; Jafar Amani; Ali Sharafi; Hossein Danafar
Journal:  Heliyon       Date:  2019-06-06

7.  Cellular and Humoral Immunogenicity Investigation of Single and Repeated Allogeneic Tenogenic Primed Mesenchymal Stem Cell Treatments in Horses Suffering From Tendon Injuries.

Authors:  Eva Depuydt; Sarah Y Broeckx; Koen Chiers; Marco Patruno; Laura Da Dalt; Luc Duchateau; Jimmy Saunders; Frederik Pille; Ann Martens; Lore Van Hecke; Jan H Spaas
Journal:  Front Vet Sci       Date:  2022-02-24

Review 8.  The Evaluation of Cellular Immunity to Avian Viral Diseases: Methods, Applications, and Challenges.

Authors:  Xiaoli Hao; Fan Zhang; Yi Yang; Shaobin Shang
Journal:  Front Microbiol       Date:  2021-12-07       Impact factor: 5.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.